• Home
  • News & IR
  • News
K-HUB
mRNA 준비된 한미약품, WHO '백신허브' 선정 노린다
2021-07-06
Bio Vaccine
NIH visits Hanmi Fine Chemical to verify mRNA technology
2021-07-01
Bio Vaccine
한미정밀화학 "국립보건연구원이 방문해 mRNA원료기술 현장검증"
2021-07-01
K-HUB
Team Korea formed to develop mRNA vaccine for complete self-sufficiency by next yr
2021-06-30
Digital Therapeutics
떠오르는 디지털 치료제, '대형 제약사' 관심도 증가
2021-06-18
K-HUB
What policy does Korea need to achieve vaccine hub ambition?
2021-06-17
Bio Vaccine
임종윤 한미사이언스 대표 “mRNA 백신 원액 단기간 내 공급 가능하다”
2021-06-16
Bio Vaccine
"백신 개발은 방위산업…컨소시엄 구축하고 대규모 투자로 자체 mRNA 개발해야"
2021-06-15
Bio Vaccine
G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021
2021-06-13
  1.   
  2. 36
  3. 37
  4. 38
  5. 39
  6. 40
  7. 41
  8. 42
  9. 43
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.